Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-25, Stock:JNJ, The news for the past five days is as follows:
2019-07-18: NEWS1: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS2: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS3: 3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement.NEWS4: Top Stock Reports for Johnson & Johnson, NextEra & Deere.NEWS5: Top Stock Reports for Johnson & Johnson, NextEra & Deere.NEWS6: Jim Cramer: Looking for Netflix Action? Don't Be a Hero.NEWS7: Top Stock Reports for Johnson & Johnson, NextEra & Deere.NEWS8: 5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report.NEWS9: 5 Signs of Life in Johnson & Johnson's Second-Quarter Earnings Report.NEWS10: Litigation Looms in the Wake of JNJ’s Solid Q2 Earnings.NEWS11: Health Care Sector Update for 07/18/2019: CODX, IDXG, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 07/18/2019: CODX, IDXG, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: 5 Signs of Life in Johnson & Johnson&apos;s Second-Quarter Earnings Report.
2019-07-19: NEWS1: Noteworthy Friday Option Activity: INTC, BGS, JNJ.NEWS2: Noteworthy Friday Option Activity: INTC, BGS, JNJ.NEWS3: Edited Transcript of JNJ earnings conference call or presentation 16-Jul-19 12:30pm GMT.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific.NEWS5: The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific.NEWS6: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS7: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific.NEWS9: Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts.NEWS10: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus.NEWS11: Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN.NEWS12: Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN.NEWS13: Dow 30 Stock Roundup: MSFT, JPM, IBM, JNJ, GS Earnings Impress.
2019-07-22: NEWS1: The 10 Biggest Blue Chip Stocks.NEWS2: The 10 Biggest Blue Chip Stocks.NEWS3: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS4: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS5: Relative Strength Alert For Johnson & Johnson.NEWS6: Relative Strength Alert For Johnson & Johnson.NEWS7: The 10 Biggest Blue Chip Stocks.NEWS8: J&J in hot water after safety lawsuits over baby powder.NEWS9: Johnson & Johnson faces more than 14k lawsuits over talc products.NEWS10: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS11: Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal.NEWS12: Companies to Watch: Equifax settles, CBS goes dark on AT&T, Vail buying Peak in ski deal.NEWS13: UPDATE 3-Congo minister's resignation over Ebola snub could unblock new vaccine.NEWS14: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS15: Stocks Slip This Week on Earnings, Fed Uncertainties.NEWS16: Is Johnson & Johnson a Buy?.
2019-07-23: NEWS1: How to Invest in Cancer-Fighting Stocks.NEWS2: Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View.NEWS3: Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View.NEWS4: Here's Why the Best Is Yet to Come for UroGen Pharma.NEWS5: Here's Why the Best Is Yet to Come for UroGen Pharma.NEWS6: SPLG, JNJ, T, WMT: ETF Inflow Alert.NEWS7: SPLG, JNJ, T, WMT: ETF Inflow Alert.NEWS8: Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View.NEWS9: Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?.NEWS10: Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?.NEWS11: Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN.NEWS13: Will Humira & Other Drugs Drive AbbVie's (ABBV) Q2 Earnings?.NEWS14: 3 of the Most Rock-Solid Dividend Stocks in the World.NEWS15: 3 of the Most Rock-Solid Dividend Stocks in the World.NEWS16: 3 of the Most Rock-Solid Dividend Stocks in the World.NEWS17: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS18: The Zacks Analyst Blog Highlights: Microsoft, JPMorgan, Merck, Johnson & Johnson and IBM.NEWS19: Drugmakers shell out record amount lobbying Congress.
2019-07-24: NEWS1: Is Johnson & Johnson Stock Losing Its Shine?.NEWS2: Health Care Sector Update for 07/24/2019: ANTM, SGEN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 07/24/2019: ANTM, SGEN, TMO, JNJ, PFE, ABT, MRK, AMGN.NEWS4: JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades.NEWS5: JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades.

Answer: Rise